Indeed, carriers of the homozygous (CTG)5 genotype in general have lower serum carnosinase-1 (CN-1) concentrations and activities (Janssen et al. 2005) which seems to afford protection against renal failure (Albrecht et al. 2017). The gene discussed is CNDP1; the disease is kidney failure.